Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome
Journal of Nephrology · 2024
DOI: 10.1007/s40620-024-02076-6 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Nephrology, 2024. Verfasst von Khairunnisa Mohamad und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia. Hauptthemen laut MEDLINE: Nephrotic Syndrome, Recurrence, Steroids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Managing children with frequent relapses or steroid-dependent nephrotic syndrome poses challenges due to recurrent relapses necessitating prolonged steroid exposure, thus increasing susceptibility to long-term complications. Identifying those at risk of poor response to steroid therapy may be helpful to guide timely intervention with steroid-sparing agents. This study aimed to identify factors associated with steroid-sparing agent needs in children with frequent relapses or steroid-dependent nephrotic syndrome. METHODS: A retrospective multicenter cohort study was conducted by reviewing the medical records of children with idiopathic nephrotic syndrome treated between 2006 and 2023. Cox proportional regression analyzed prognostic factors for steroid-sparing agent requirements in children with frequent relapses or steroid-dependent nephrotic syndrome. The time-to-event analysis utilizing the Kaplan-Meier estimate examined the proportion of children needing steroid-sparing agents after diagnosis. RESULTS: Medical records of 121 children (85 males) diagnosed with idiopathic nephrotic syndrome at a median age of 4.5 years (range 1.3-12.8) were reviewed over a median follow-up of 3.7 years (range 1.0-15.0). Time to subsequent relapse post-frequent relapses or steroid-dependent nephrotic syndrome diagnosis (at 3-month threshold) emerged as the sole significant predictor of steroid-sparing agent requirement, adjusted hazard ratio (aHR) = 2.26, 95% confidence interval (CI) 1.26-4.05. Kaplan-Meier analysis indicated that an earlier first relapse (< 3 months) led to earlier steroid-sparing agent requirement (log-rank p = 0.005). Children who relapsed within 3 months post-frequent relapses or steroid-dependent nephrotic syndrome diagnosis exhibited a higher frequency of relapses, a greater incidence of steroid-related adverse events, and were more likely to develop steroid dependency. CONCLUSIONS: Early subsequent relapse following diagnosis of frequent relapses or steroid-dependent nephrotic syndrome was linked to earlier requirement of steroid-sparing agent therapy. Further prospective research is necessary to confirm this observation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
- Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia. hadz@usm.my.
- Department of Clinical Medicine, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
- Department of Paediatric, Hospital Sultanah Nur Zahirah, Ministry of Health Malaysia, Terengganu, Malaysia.
Zitieren
APA
Mohamad, K., Zainal, H., Abdul Rahim, N. A., & Tengku Hussain, T. H. (2024). Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome. Journal of Nephrology. https://doi.org/10.1007/s40620-024-02076-6
Vancouver
Mohamad K, Zainal H, Abdul Rahim NA, Tengku Hussain TH. Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome. Journal of Nephrology. 2024. doi:10.1007/s40620-024-02076-6
BibTeX
@article{Mohamad2024,
author = {Mohamad, Khairunnisa and Zainal, Hadzliana and Abdul Rahim, Nur Arzuar and Tengku Hussain, Tengku Hasnita},
title = {Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome},
journal = {Journal of Nephrology},
year = {2024},
doi = {10.1007/s40620-024-02076-6}
}
EUVIMED